Pharmacy Creations Certain Products: Recall – Potential Non-Sterility
Compromised sterility of a product may lead to risk for infection
Italiano
Compromised sterility of a product may lead to risk for infection
L'Agenzia Italiana del Farmaco rende disponibili nuove e importanti
informazioni sull'uso off-label di basiliximab nel trapianto di cuore.
Compromised sterility of a compounded preparation may lead to risk for infection.
Using these Dermatend products instead of seeking medical attention could result in delayed diagnosis of conditions such as cancer.
Infants at highest risk for injury. Sudden obstruction of trachea could lead to respiratory arrest/death. In all patient populations, failure may result in need for surgical intervention to replace failed device.
L'Agenzia Italiana del Farmaco rende disponibili nuove e importanti raccomandazioni per minimizzare il rischio di osteonecrosi della mandibola/mascella (ONJ) e di ipocalcemia durante il trattamento con Prolia e Xgeva.
Potential adhesion defect which may lead to infection.
Cladosporium and Penicillium Fungi which may cause difficulty in breathing, allergic reactions and serious health consequences, including death.
80.211.154.110